Return to study ST000050 main page

MB Sample ID: SA002198

Local Sample ID:UPCON0003
Subject ID:SU000068
Subject Type:Human
Subject Species:Homo sapiens
Taxonomy ID:9606
Gender:24 female; 16 male
Species Group:Human

Select appropriate tab below to view additional metadata details:


Subject:

Subject ID:SU000068
Subject Type:Human
Subject Species:Homo sapiens
Taxonomy ID:9606
Gender:24 female; 16 male
Species Group:Human

Factors:

Local Sample IDMB Sample IDFactor Level IDLevel ValueFactor Name
UPCON0003 SA002198FL000664PoolAcute Kidney Injury

Collection:

Collection ID:CO000051
Collection Summary:-
Sample Type:Urine

Treatment:

Treatment ID:TR000069

Sample Preparation:

Sampleprep ID:SP000064
Sampleprep Summary:Frozen urine study samples were thawed on ice and vortexed for 30 seconds. Each of the 40 urine samples (200 µL) were prepared individually by addition of 25 µL D20 and 25 µL Chenomx Internal Standard (Chenomx ISTD, Edmonton, Alberta, Canada). Phenotypic pools for AKI and no AKI were generated with 60 µL of each urine sample pooled, mixed, divided into 3 aliquots. Additionally, 400 µL from both phenotypic pools were mixed to form a total pooled sample and divided into 3 aliquots. The pooled samples were prepared identically to the individual study samples. 1H NMR spectra of urine samples were acquired on a Bruker Avance 950 MHz NMR spectrometer (located at the David H. Murdock Research Institute at Kannapolis, NC, USA) using a 3 mm cryogenically cooled ATMA inverse probe and ambient temperature of 25℃. A 1D NOESY presaturation pulse sequence (noesypr1d, [recycle delay (RD)-90°-t1-90°-tm-90°-acquire free induction decay (FID) was used for data acquisition. For each sample 64 transients were collected into 65k data points using a spectral width of 14.01 kHz (20.14 ppm), 2 s relaxation delay, 100 ms mixing time, and an acquisition time of 2.324 s per FID. The water resonance was suppressed using resonance irradiation during the relaxation delay and mixing time. NMR spectra were processed using Chenomx NMR Suite 7.51 Professional (Chenomx, Edmonton, Alberta, Canada) software. Spectra were zero filled, and Fourier transformed after exponential multiplication with line broadening factor of 0.5. Phase and baseline of the spectra were manually corrected for each spectrum. Spectra were referenced internally to the DSS signal. The quality of each NMR spectrum was assessed for the level of noise and alignment of identified markers. Spectra were assessed for missing data and underwent quality checks. NMR bins (0.50-9.0 ppm) were made after excluding DSS, water (4.68-4.80 ppm), and Imidazole (7.20-7.28 ppm) using bucket Integration with a 0.04 ppm bucket width. Integrals of each of the bins were normalized to total integral of each of the spectrum.
Sampleprep Protocol Filename:RTI_NeonatalAKI_Metabolomics_Procedure.docx

Analysis:

MB Sample ID:SA002198
Analysis ID:AN000086
Laboratory Name:RTI
Analysis Type:NMR
Software Version:Top Spin 3.2
Chromatography ID:CH000055
Num Factors:3

NMR:

NMR ID:NM000023
Analysis ID:AN000086
Instrument Name:Bruker Avance III
Instrument Type:FT-NMR
NMR Experiment Type:1D 1H
Field Frequency Lock:Deuterium
Standard Concentration:0.5mM
Spectrometer Frequency:950 MHz
NMR Probe:cyrogenically cooled ATMA inverse probe
NMR Solvent:D2O
NMR Tube Size:3mm
Shimming Method:Gradient
Pulse Sequence:NOESYpr1d
Water Suppression:yes
Pulse Width:19.9298
Receiver Gain:4
Offset Frequency:4468.3
Chemical Shift Ref Cpd:formate
Temperature:25 degrees celsius
Number Of Scans:64
Dummy Scans:4
Acquisition Time:1.73 seconds
Spectral Width:19.9298
Num Data Points Acquired:65536
Real Data Points:65536
Line Broadening:0.5
Zero Filling:yes
Apodization:Lorentzian
Baseline Correction Method:quad
  logo